PredxBio

Access our brand new White Paper here

Menu

Our Journey

Our Purpose

Shaping the Future of Spatially Intelligent Biology

We believe the convergence of unbiased spatial analytics and explainable AI ushers in a new era of spatially intelligent biology. The novel insights from our platforms reveal the existence of intermediate cell types and their functional states as well as communications between them.

We offer software as a service (SaaS) applications as well as knowledge -based contracted services, harnessing proprietary explainable AI and unbiased spatial analytics. Our solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. 

Our Milestones

2018
Company Formed
2019
HistoMapr SBIR Awarded
2020
  • Nature Communications Publication
  • Advances in Anatomic Pathology Publication
  • Partnership with CellNetix Pathology and Laboratories
2021
  • Cell Reports Methods Publication
  • Partnership with Allegheny Health Network
  • Investment from Innovation Works
  • First Patent Awarded
2022 – Q1-Q2
  • Initial Commercialization
  • USCAP 2022 & AACR 2022 Exhibitor/Presenter

2018

Company Formed

2019

HistoMapr SBIR Awarded

2020

Nature Communications Publication
Advances in Anatomic Pathology Publication
Partnership with CellNetix Pathology and Laboratories

2021

Cell Reports Methods Publication
Partnership with Allegheny Health Network
Investment from Innovation Works
First Patent Awarded

2022 – Q1-Q2

Initial Commercialization
USCAP 2022 & AACR 2022 Exhibitor/Presenter

Our Unique Value Proposition

Get two steps ahead in spatial biology

  • Unbiased Spatial Analytics
  • Explainable AI

Cutting edge technology

  • 20+ peer-reviewed publications
  • Dominant IP position

Adaptive and
agnostic solutions

  • Transmitted light and multi-hyperplexed
  • Any imaging platform

Leading academic medical center and pathology practice collaborations

  • Roswell Park Comprehensive Cancer Center
  • Allegheny Health Network
  • CellNetix Pathology and Laboratories

Deep scientific
expertise

  • 100+ years of experience in computational and systems pathology, bioimaging, and AI

Subscribe to our Newsletter

* indicates required

We received your request! One of our team members will be in touch as soon as possible.

Submit your Resume

Download Whitepaper

Download Whitepaper

B. Dusty Majumdar, PhD

CHIEF EXECUTIVE OFFICER

Linkedin-in

B. Dusty Majumdar, PhD  is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across oncology, multi-omics, Real-World Evidence (RWE). diagnostic imaging and liquid biopsy platforms leveraging some of the industry’s most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies. Dr. Majumdar’s experience includes leading strategy and marketing as the Chief Marketing Officer (CMO) at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M. He has also led the commercial and strategic functions in a range of start-ups in the healthcare/biopharma space over the last few years.  Dr. Majumdar is a widely respected global leader in the healthcare industry and holds a Ph.D. from the University of Texas at Austin and a bachelor’s degree from the Indian Institute of Technology (IIT), Kharagpur.  He has authored several peer-reviewed scientific publications and holds multiple patents.

Joe Camaratta

Sr. VP Business Development

Linkedin-in

Joe Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He held executive positions for GE Healthcare and Siemens Healthcare and built businesses in medical imaging, cardiology, and oncology. He founded and led two early stage medical technology companies that apply artificial intelligence to improve clinical decision-making.

Joe holds a Master of Science degree in Computer Science from Rutgers University and a Bachelor of Science degree in Computer Science from Drexel University. He currently serves as an advisor to the Entreprenuerial Investing Program of the Crohn’s & Colitis Foundation, and the University Science Center QED Program focused on commercialization of academic innovations

Bruce Campbell, MS

VP Software Engineering

Linkedin-in

Bruce leads the software engineering and quality assurance teams at PredxBio. As the VP of Software Engineering, he is responsible for analytical infrastructure, product development and the commercialization of machine learning, image processing, and computational biology algorithms. Prior to joining PredxBio, Bruce was at IBM and Xylem in global Director of Data Science roles. He has over 20 years of experience in digital pathology algorithms and is highly motivated to deliver care through digital and computational pathology. He has multiple successful FDA 510k device applications, and multiple CLIA certified algorithms deployed in clinical practice.

Bruce holds a BS in Physics and MS in Applied Mathematics from the University of Rochester, an MS in Statistics from North Carolina State University, and is currently pursuing graduate mathematics studies at The Ohio State University. Bruce loves the outdoors. You can find him hiking and rock climbing in Appalachia.